Edesa Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Edesa Biotech generated cash of -$4,890,205, which is more than the previous year. Cash used in financing activities reached the amount of $592,031 last year. Net change in cash is therefore -$4,324,077.
Cash Flow
| 2015 | -4.41M | 122.47K | 106.77K |
|---|---|---|---|
| 2016 | -4.50M | 557.41K | 7.31M |
| 2017 | -4.69M | 1.69M | 5.91K |
| 2018 | -4.61M | -4.46M | 8.77M |
| 2019 | -4.84M | 6.41M | 0 |
| 2020 | -4.98M | 19.07K | 7.09M |
| 2021 | -13.66M | -6.14K | 14.17M |
| 2022 | -12.27M | -5.65K | 11.62M |
| 2023 | -6.63M | 0 | 4.83M |
| 2024 | -4.89M | 0 | 592.03K |
EDSA Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.36M | 7.09M | 7.83M | 7.21M | 5.03M | 3.36M | 4.57M | 7.41M | 3.95M | 8.76M |
Operating activities | ||||||||||
Net income | -6.17M | -8.37M | -17.54M | -13.34M | -6.36M | -2.77M | -5.03M | -5.03M | -5.02M | -2.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 186.04K | 183.47K | 118.18K | 118.78K | 57.56K | 4.77K | 188.37K | 179.32K | 149.56K | 159.52K |
Stock-based compensation expense | 537.49K | 1.24M | 2.26M | 3.19M | 598.35K | 46.50K | 0 | 115.54K | 259.37K | 267.22K |
| Deferred income tax benefit | 537.49K | 1.24M | 2.26M | 3.19M | 598.35K | 46.50K | 0 | 115.54K | 259.37K | 267.22K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 356.33K | 562.77K | 2.02B | -3.22M | 127.13K | 9.73K | -40.00K | 84.57K | 71.82K | -113.91K |
Inventories | 0 | 0 | 0 | 0 | 0 | 77.91K | -156.15K | 181.31K | 307.85K | -522.38K |
Accounts payable | 17.59K | -556.27K | 882.84K | -124.72K | 998.90K | -1.88M | 172.45K | -302.73K | -230.55K | 31.26K |
Cash generated by operating activities | -4.89M | -6.63M | -12.27M | -13.66M | -4.98M | -4.84M | -4.61M | -4.69M | -4.50M | -4.41M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -500K | 0 | -9.08M | -5.00M | -11.99M | -13.67K |
Investments In Property Plant And Equipment | 0 | 3 | -5.65K | -6.14K | -34.33K | -8.09K | -382.81K | -302.73K | -402.27K | -274.58K |
Acquisitions Net | 0 | 0 | 0 | 0 | 29.48K | 6.38M | 0 | 0 | -66.69K | 0 |
Cash generated by investing activities | 0 | 0 | -5.65K | -6.14K | 19.07K | 6.41M | -4.46M | 1.69M | 557.41K | 122.47K |
Financing activities | ||||||||||
Common Stock Issued | 729.38K | 4.34M | 11.95M | 12.66M | 4.36M | 0 | 4.52M | 0 | 5.94M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -29.53K | 0 | 0 | 0 | -29.74K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 592.03K | 4.83M | 11.62M | 14.17M | 7.09M | 0 | 8.77M | 5.91K | 7.31M | 106.77K |
Net Change In Cash | -4.32M | -1.72M | -748.34K | 625.56K | 2.18M | 1.66M | -345.43K | -2.84M | 3.46M | -4.81M |
Cash at end of period | 1.03M | 5.36M | 7.09M | 7.83M | 7.21M | 5.03M | 4.22M | 4.57M | 7.41M | 3.95M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |